Pharma & Bio
Lifestyle
GemVax & KAEL Co.,Ltd.: Expectations for Conditional Approval of Progressive Nuclear Paralysis Treatment… Preclinical Trials for ALS Also Show ‘Positive Signs’
GV1001, a new drug candidate from GemVax & KAEL Co.,Ltd.(082270)that is raising expectations for conditional approval in the field of progressive supranuclear palsy (PSP)—for which there are currently…
Business·Industry
'Taking on Legal Challenges Head-On': Shaperon Inc. Picks NezTech… 'Expanding into North America with Beauty DEVICES'
It has been known since last April that Shaperon Inc. ( Shaperon Inc.(378800)), a developer of new drugs for immune and inflammatory diseases, has been seeking merger and acquisition (M&A) targets. At…
Business·Industry
Macrogen, Inc. Transitions from Korea’s No. 1 NGS Provider to a Digital Healthcare Platform Company… ‘Profitability Remains a Challenge’
Macrogen, Inc.(038290)is pursuing a transformation from the leading company in South Korea’s next-generation sequencing (NGS) market to a digital healthcare platform company. The company plans to expa…
Lifestyle
[BioUSA] Moon Young-jun, Head of Business Development at NEUROPHET Inc.: “In Discussions for Additional Agreements with Roche and Lilly... Expecting to Turn a Profit Next Year”
At Bio USA, held in San Diego, U.S., global pharmaceutical companies are showing keen interest in imaging biomarker technology amid the expanding market for Alzheimer’s treatments. In particular, NEUR…
Lifestyle
Kim Nam-kyu, CEO of La Défense: “We’ve Left All Possibilities Open for OSCOTEC Inc., Including System Integration and Equity Participation”
“We are keeping all possibilities open, including attracting strategic investors (SIs) and equity participation. The key point is that this is not a hostile takeover aimed at short-term gains; rather,…
Lifestyle
EnSol Bio 'Loads Its Ammo,' Expanding Beyond Degenerative Diseases into Cancer and Brain Disorders
Ensol Biosciences (Ensol Bio), a leading player in the KONEX market, is expanding its reach beyond treatments for degenerative diseases into the fields of cancer and brain disorders. The company’s lar…
Business·Industry
Rokit and AprilBio Hit Daily Price Limit...HanAll Jumps on Its Own Catalyst [K-Bio Pulse]
The biotech and healthcare sector experienced a rare surge in positive momentum on June 24, driven by optimism surrounding the 2026 BIO International Convention, also known as BIO USA, the world’s lar…
Business·Industry
Rocket, Hanol, and AprilSoar Amid Positive Sentiment from 'Bio USA'… What’s Behind It? [Bio Insight]
On the 24th, the biotech and healthcare sector saw a rare upswing, driven by the impact of the “2026 Bio International Convention (Bio USA),” the world’s largest biotech exhibition.
KOSDAQ Stock In…
Technology
"From Dreams and Stories to Financial Statements"... The Stock Market Proves the Criteria for Leading K-Bio Stocks [Bio Companies with Solid Numbers, Part 1]
As the domestic stock market has shifted to a performance-driven market centered on semiconductors, attention is also growing in the pharmaceutical, biotech, and healthcare sectors, particularly towar…
Lifestyle
A Rush to Develop Mesenchymal Stem Cell-Based Curative Treatments for Osteoarthritis... What Are the Key Points?
As the global population continues to age, the number of patients with knee osteoarthritis is rapidly increasing. Consequently, active research is underway in South Korea to develop a disease-modifyin…